Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Roux-en-Y gastric bypass on citalopram pharmacokinetics
NL-OMON55680Not yet recruiting
- Sponsor
- Maasstad Ziekenhuis
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of citalopram in major depressive disorder (MDD), sponsored by Maasstad Ziekenhuis. Primary endpoint: Citalopram AUC at 3 months after surgery versus baseline. Planned start Sep 2017; status: not yet recruiting.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON55680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55680.